Regardless of what being downramp here... Non-holder will have -ve things to say and that is their game to play.
DYOR and then invest. If you look back at Marc experience and listen many his current conference talks in August. He seem to understand about next boom of resource and what required for big project like magnis.
And I believe Peter as CFO playing main key too. Funding and pushing for the project move forward.
- Forums
- ASX - By Stock
- MNS
- Ann: Key Board Appointments-MNS.AX
Ann: Key Board Appointments-MNS.AX, page-45
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online